Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase I Study of Intrathecal Spartaject-Busulfan in Patients With Neoplastic Meningitis

NCT00003462 is registered in ClinicalTrials.gov with Duke University as lead sponsor.

NCT NCT00003462
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00003462 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase I Study of Intrathecal Spartaject-Busulfan in Patients With Neoplastic Meningitis
Lead sponsor
Duke University
Phase
Phase 1
Overall status
Completed
Start date
April 30, 1998
Completion date
February 28, 2001
Enrollment
20 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

brain and central nervous system tumors